USP and DSP (development) | rHSA | Yeast and Microbial Expression | GMP | ISO 13485 | Recombinant Proteins and Enzymes Manufacturing Services
Basic Pharma is a full-service provider located in the Netherlands that specializes in (bio)pharmaceutical product development, registration, manufacturing, and commercialization. The company focuses on developing and producing semi-solid formulations, such as creams, gels, and ointments, as well as liquid preparations, including nasal sprays, injectables, and syrups. Basic Pharma is a strategic partner to the pharmaceutical industry, academic institutions, and biotech start-ups, offering tailored services throughout the product lifecycle.
In addition to these core pharmaceutical activities, Basic Pharma’s biotech department offers well-established infrastructure for recombinant protein production services and is progressing toward GMP compliance. The biotech department provides the infrastructure and expertise necessary to produce recombinant proteins for various applications, including:
Basic Pharma also offers a portfolio of high-quality recombinant proteins, each of which is rigorously tested to ensure consistent biological activity. Each batch is delivered with a Certificate of Analysis (CoA) that meets the stringent quality standards required for your research and development applications.
Recombinant Human Serum Albumin (rHSA) is a vital plasma protein that plays a key role in maintaining oncotic pressure and facilitating the transport of various endogenous and exogenous substances. Our recombinant rHSA is produced using Hansenula polymorpha yeast, offering a high-purity, animal-free alternative to traditional serum-derived HSA. It is ideal for applications requiring consistency, safety, and regulatory compliance.
All Products are for Research Use Only.
We gladly support you by keeping you updated on our latest products and the developments around our services.